|
|||||
Year/Semester of Study | 4 / Fall Semester | ||||
Level of Course | 1st Cycle Degree Programme | ||||
Type of Course | Optional | ||||
Department | MOLECULAR BIOLOGY AND GENETICS | ||||
Pre-requisities and Co-requisites | None | ||||
Mode of Delivery | Face to Face | ||||
Teaching Period | 14 Weeks | ||||
Name of Lecturer | NAŞİT İĞCİ (nasitigci@nevsehir.edu.tr) | ||||
Name of Lecturer(s) | CEVAHİR ALTINKAYNAK, | ||||
Language of Instruction | Turkish | ||||
Work Placement(s) | None | ||||
Objectives of the Course | |||||
The aim of this course is to provide information on the identification, production, purification, characterization and mechanism of action of molecules used as therapeutic agents using protein engineering approaches. |
Learning Outcomes | PO | MME | |
The students who succeeded in this course: | |||
LO-1 | can explain about the structure, classification, function and aggregation of proteins. |
PO-3 Identify structure-function relationships in cells and organisms PO-6 Develop an understanding of nature and history of scientific thought PO-9 Find out new methods to improve his/her knowledge PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
LO-2 | can explain the separation, purification, characterization and chemical modifications of proteins. |
PO-6 Develop an understanding of nature and history of scientific thought PO-9 Find out new methods to improve his/her knowledge PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
LO-3 | can explain the methods of protein engineering. |
PO-6 Develop an understanding of nature and history of scientific thought PO-8 Develop an awareness of continuous learning in relation with modern technology PO-13 Obtain knowledge about current issues in the field of molecular biology and genetics |
Examination |
LO-4 | can explain therapeutic proteins and the strategies of production. |
PO-11 Apply biological concepts to personal, social, economical, technological and ethical issues PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
LO-5 | can explain about the definition of antibody, monoclonal antibody and antibody fragments and mechanism of action |
PO-13 Obtain knowledge about current issues in the field of molecular biology and genetics PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
LO-6 | can explain biosimilars and its uses in clinical practice. |
PO-13 Obtain knowledge about current issues in the field of molecular biology and genetics PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
LO-7 | can explain about venom peptides. |
PO-13 Obtain knowledge about current issues in the field of molecular biology and genetics PO-16 Explain the scientific findings clearly and efficiently both in written and verbal communications. |
Examination |
PO: Programme Outcomes MME:Method of measurement & Evaluation |
Course Contents | ||
Protein structure, classification, function, protein purification and characterization, chemical modification, protein engineering methods, classification of therapeutic proteins (EPO, insulin, interferon alpha and beta, blood factors, colony stimulating factors, interleukins, growth factors, monoclonal antibodies), recombinant production strategies, antibody structure and functions, monoclonal antibody production technology, biosimilars and clinical uses, venom peptides. | ||
Weekly Course Content | ||
Week | Subject | Learning Activities and Teaching Methods |
1 | Classification of Proteins and its Functions and Structures | Expression Question-Answer |
2 | Function and aggregation of proteins | Expression Question-Answer |
3 | Separation, purification and characterization of proteins | Expression Question-Answer |
4 | Chemical Modification of Proteins | Expression Question-Answer |
5 | The aims of protein engineering | Expression Question-Answer |
6 | Protein engineering methods | Expression Question-Answer |
7 | Classification of therapeutic proteins | Expression Question-Answer |
8 | mid-term exam | |
9 | Therapeutic proteins and the strategies of recombinant production | Expression Question-Answer |
10 | Antibody structure and function | Expression Question-Answer |
11 | Monoclonal antibody production methods and mechanism of action | Expression Question-Answer |
12 | Engineering antibody therapeutics | Expression Question-Answer |
13 | Biosimilars | Expression Question-Answer |
14 | Problems to be encountered in clinical practice in biosimilars | Expression Question-Answer |
15 | Venom Peptides | Expression Question-Answer |
16 | final exam | |
Recommend Course Book / Supplementary Book/Reading | ||
1 | Therapeutic Proteins-Vladimir Voynov-Humana Press | |
2 | Biyoteknolojiye Giriş- William J. Thieman/Michael A. Palladino | |
3 | Güncel Biyoteknoloji ve Uygulamaları-Münis Dündar/Haydar Bağış | |
4 | Protein Mühendisliği- Azmi telefoncu/Ö.İrfan Küfrevioğlu/Figen Zihnioğlu/Ali Kılınç | |
Required Course instruments and materials | ||
Assessment Methods | |||
Type of Assessment | Week | Hours | Weight(%) |
mid-term exam | 8 | 1 | 40 |
Other assessment methods | |||
1.Oral Examination | |||
2.Quiz | |||
3.Laboratory exam | |||
4.Presentation | |||
5.Report | |||
6.Workshop | |||
7.Performance Project | |||
8.Term Paper | |||
9.Project | |||
final exam | 16 | 1 | 60 |
Student Work Load | |||
Type of Work | Weekly Hours | Number of Weeks | Work Load |
Weekly Course Hours (Theoretical+Practice) | 2 | 14 | 28 |
Outside Class | |||
a) Reading | 2 | 14 | 28 |
b) Search in internet/Library | 2 | 8 | 16 |
c) Performance Project | 0 | ||
d) Prepare a workshop/Presentation/Report | 0 | ||
e) Term paper/Project | 0 | ||
Oral Examination | 0 | ||
Quiz | 0 | ||
Laboratory exam | 0 | ||
Own study for mid-term exam | 4 | 2 | 8 |
mid-term exam | 1 | 1 | 1 |
Own study for final exam | 4 | 2 | 8 |
final exam | 1 | 1 | 1 |
0 | |||
0 | |||
Total work load; | 90 |